Liabilities, Current in USD of OnKure Therapeutics, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: OnKure Therapeutics, Inc. quarterly Liabilities, Current history and growth rate from Q4 2020 to Q3 2025.
OnKure Therapeutics, Inc. Liabilities, Current for the quarter ending September 30, 2025 was $6.25M, a 92.3% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

OnKure Therapeutics, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$6.25M	+$3M	+92.3%	Sep 30, 2025	10-Q	2025-11-06
Q2 2025	$7.6M	+$6.25M	+464%	Jun 30, 2025	10-Q	2025-08-12
Q1 2025	$8.79M	+$5.97M	+212%	Mar 31, 2025	10-Q	2025-05-06
Q4 2024	$10.5M	+$3.25M	+44.5%	Dec 31, 2024	10-Q	2025-11-06
Q3 2024	$3.25M	-$10.3M	-76.1%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$1.35M	-$12.4M	-90.2%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$2.81M	-$7.67M	-73.2%	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$7.29M	+$161K	+2.26%	Dec 31, 2023	10-K	2025-03-10
Q3 2023	$13.6M	+$4.11M	+43.5%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$13.7M	+$5.4M	+64.8%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$10.5M	+$2.57M	+32.5%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$7.12M	+$922K	+14.9%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$9.45M	+$3.1M	+48.7%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$8.34M	+$5M	+150%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$7.91M	+$3.98M	+101%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$6.2M	+$1.62M	+35.4%	Dec 31, 2021	10-K	2023-03-27
Q3 2021	$6.35M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$3.34M			Jun 30, 2021	10-Q	2021-08-11
Q1 2021	$3.93M			Mar 31, 2021	10-Q	2021-05-20
Q4 2020	$4.58M			Dec 31, 2020	10-K	2022-03-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.